Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database.

BMC Cancer · 2025 · PMC12335178 · PMID 40781661

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In endocrine disorders (Table 10 ): adrenocorticotropic hormone deficiency (ROR = 327.92) and immune-mediated adrenal insufficiency (ROR = 321.26) were highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.